insights_auto
Why is GALT down 2.87%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.05
arrow_downward
-2.87%(-0.090) 1D
$3.10
arrow_upward
+1.64% (+0.050)todayPre-market
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.16
High
$3.31
Low
$2.93
Mkt. cap
307.59M
Avg. vol.
204.32K
Volume
1.01K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.16
High
$3.31
Low
$2.93
Mkt. cap
307.59M
Avg. vol.
204.32K
Volume
1.01K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
24/7 Wall St.
·
14 minutes ago
2 Safe S&P 500 Financial Dividend Stocks Boomers Can Buy and Hold Forever
Business Insider
·
2 hours ago
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Investing.com
·
1 hour ago
Barclays joins Morgan Stanley in seeing S&P 500 at 8,700 by end-2027
Traders Union
·
48 minutes ago
Caleb Franzen: S&P 500 futures fall 0.13% as Bitcoin futures drop 5.56%
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com